Fexofenadine Hydrochloride is an antihistamine used to treat allergic symptoms of seasonal allergic rhinitis (sneezing, runny nose, itchy or watery eyes), and urticaria (hives). 

The global Fexofenadine Hydrochloride market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Fexofenadine Hydrochloride volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fexofenadine Hydrochloride market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fexofenadine Hydrochloride in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fexofenadine Hydrochloride manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Viruj
ACIC Pharmaceuticals
Sumitomo Chemical
Sibram
Jubilant Pharma
Flagship Biotech International
Archerchem
Vasudha Pharam
Panchsheel
GenPharma
Apintus Labs

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Purity:98%
Purity:>98%

Segment by Application
Seasonal Allergic Rhinitis
Urticaria